Cited 14 times in
The HOPE Asia network 2022 up-date consensus statement on morning hypertension management
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 박성하 | - |
dc.date.accessioned | 2023-03-21T07:28:58Z | - |
dc.date.available | 2023-03-21T07:28:58Z | - |
dc.date.issued | 2022-09 | - |
dc.identifier.issn | 1524-6175 | - |
dc.identifier.uri | https://ir.ymlib.yonsei.ac.kr/handle/22282913/193394 | - |
dc.description.abstract | Morning hypertension is an important clinical target in the management of hypertension for perfect 24-h blood pressure (BP) control. Morning hypertension is generally categorized into two types: "morning surge" type and "sustained nocturnal and morning hypertension" type. The "morning surge" type is characterized by an exaggerated morning blood pressure surge (MBPS), and the "sustained nocturnal and morning hypertension" type with continuous hypertension from nighttime to morning (non-dipper/riser type). They can be detected by home and ambulatory blood pressure measurements (HBPM and ABPM). These two forms of morning hypertension both increase the risk of cardiovascular and renal diseases, but may occur via different pathogenic mechanisms and are associated with different conditions. Morning hypertension should be treated to achieve a morning BP level of < 135/85 mmHg, regardless of the office BP. The second target morning BP levels is < 125/75 mmHg for high-risk patients with morning hypertension and concomitant diseases. Morning hypertension is more frequently found in Asians, than in Westerners. Thus, the management of morning hypertension is especially important in Asia. The detection of morning hypertension and the individual home BP-guided treatment approach targeting morning BP in combination with ABPM, and the optimal treatment of morning hypertension would reduce cardiovascular events in Asia. | - |
dc.description.statementOfResponsibility | open | - |
dc.language | English | - |
dc.publisher | Wiley Periodicals Inc. | - |
dc.relation.isPartOf | JOURNAL OF CLINICAL HYPERTENSION | - |
dc.rights | CC BY-NC-ND 2.0 KR | - |
dc.subject.MESH | Antihypertensive Agents / therapeutic use | - |
dc.subject.MESH | Asia / epidemiology | - |
dc.subject.MESH | Blood Pressure / physiology | - |
dc.subject.MESH | Blood Pressure Monitoring, Ambulatory | - |
dc.subject.MESH | Circadian Rhythm | - |
dc.subject.MESH | Consensus | - |
dc.subject.MESH | Humans | - |
dc.subject.MESH | Hypertension* / diagnosis | - |
dc.subject.MESH | Hypertension* / drug therapy | - |
dc.subject.MESH | Hypertension* / epidemiology | - |
dc.title | The HOPE Asia network 2022 up-date consensus statement on morning hypertension management | - |
dc.type | Article | - |
dc.contributor.college | College of Medicine (의과대학) | - |
dc.contributor.department | Dept. of Internal Medicine (내과학교실) | - |
dc.contributor.googleauthor | Kazuomi Kario | - |
dc.contributor.googleauthor | Ji-Guang Wang | - |
dc.contributor.googleauthor | Yook-Chin Chia | - |
dc.contributor.googleauthor | Tzung-Dau Wang | - |
dc.contributor.googleauthor | Yan Li | - |
dc.contributor.googleauthor | Saulat Siddique | - |
dc.contributor.googleauthor | Jinho Shin | - |
dc.contributor.googleauthor | Yuda Turana | - |
dc.contributor.googleauthor | Peera Buranakitjaroen | - |
dc.contributor.googleauthor | Chen-Huan Chen | - |
dc.contributor.googleauthor | Hao-Min Cheng | - |
dc.contributor.googleauthor | Minh Van Huynh | - |
dc.contributor.googleauthor | Jennifer Nailes | - |
dc.contributor.googleauthor | Apichard Sukonthasarn | - |
dc.contributor.googleauthor | Yuqing Zhang | - |
dc.contributor.googleauthor | Jorge Sison | - |
dc.contributor.googleauthor | Arieska Ann Soenarta | - |
dc.contributor.googleauthor | Sungha Park | - |
dc.contributor.googleauthor | Guru Prasad Sogunuru | - |
dc.contributor.googleauthor | Jam Chin Tay | - |
dc.contributor.googleauthor | Boon Wee Teo | - |
dc.contributor.googleauthor | Kelvin Tsoi | - |
dc.contributor.googleauthor | Narsingh Verma | - |
dc.contributor.googleauthor | Satoshi Hoshide | - |
dc.identifier.doi | 10.1111/jch.14555 | - |
dc.contributor.localId | A01512 | - |
dc.relation.journalcode | J01320 | - |
dc.identifier.eissn | 1751-7176 | - |
dc.identifier.pmid | 36196465 | - |
dc.subject.keyword | Asia | - |
dc.subject.keyword | antihypertensive medication | - |
dc.subject.keyword | bedtime dosing | - |
dc.subject.keyword | hypertension | - |
dc.subject.keyword | morning | - |
dc.subject.keyword | personalized approach | - |
dc.contributor.alternativeName | Park, Sung Ha | - |
dc.contributor.affiliatedAuthor | 박성하 | - |
dc.citation.volume | 24 | - |
dc.citation.number | 9 | - |
dc.citation.startPage | 1112 | - |
dc.citation.endPage | 1120 | - |
dc.identifier.bibliographicCitation | JOURNAL OF CLINICAL HYPERTENSION, Vol.24(9) : 1112-1120, 2022-09 | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.